The shape-shifting telehealth company has spent the past year trying to cash in on GLP-1s, the hottest drug to hit weight loss in decades. It could all slip away. By Madison Muller and Devin Leonard

The Enchanted, Steamy, Booming Romantasy Business
23:16

The Next Spotify—Or an AI Music Slop Machine?
19:06

Candy Crush's Sweet Success
12:36